Termination of Registration of a Class of Security Under Section 12(g) (15-12g)

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number

000-51541

 

Genomic Health, Inc.

(Exact name of registrant as specified in its charter)

 

301 Penobscot Drive

Redwood City, California

[phone]

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common Stock, par value $0.0001 per share

(Title of each class of securities covered by this Form)

 

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

	Rule 12g-4(a)(1)	x
	Rule 12g-4(a)(2)	o
	Rule 12h-3(b)(1)(i)	x
	Rule 12h-3(b)(1)(ii)	o
	Rule 15d-6	o
	Rule 15d-22(b)	o

 

Approximate number of holders of record as of the certification or notice date: 1

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Genomic Health, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date:	November 18, 2019		By:	/s/ Jeffrey T. Elliott
			Name:	Jeffrey T. Elliott
			Title:	Chief Financial Officer

 

---